SCHEMBL3432541

SCHEMBL3432541

OC(c1ccc2nccn2c1)c1cnc2c(Cl)ccnn12

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 1/20 0.36
MET P08581 2/20 0.36
NQO2 P16083 1/20 0.36
MAOB P27338 1/20 0.34
DYRK1A Q13627 2/20 0.33
KEAP1 Q14145 1/20 0.33
DAO P14920 1/20 0.32
TGFBR1 P36897 3/20 0.32
CPB2 Q96IY4 1/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
KMT2A Q03164 1/20 0.32
AXL P30530 1/20 0.31
FLT3 P36888 1/20 0.31
MERTK Q12866 1/20 0.31
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
JAK2 O60674 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3411255 0.79 DYRK1A (0.40) S1PR3METNQO2MAOBDYRK1A
Bromoethane SCHEMBL3414106 0.73 DYRK1A (0.35) S1PR3METNQO2DYRK1AKEAP1
SCHEMBL3413945 0.71 KEAP1 (0.46) METDYRK1AKEAP1DAOCPB2
SCHEMBL3414108 0.71 DYRK1A (0.34) S1PR3METNQO2DYRK1AKEAP1
SCHEMBL3431615 0.70 FYN (0.53) METNQO2DYRK1A
SCHEMBL3636986 0.67 CPB2 (0.45) S1PR3MAOBDYRK1AKEAP1DAO
SCHEMBL12489426 0.66 DYRK1A (0.46) S1PR3METNQO2MAOBDYRK1A
SCHEMBL24087284 0.66 DYRK1A (0.49) S1PR3METNQO2DYRK1AKEAP1
SCHEMBL13692842 0.65 MET (0.35) METNQO2
SCHEMBL3409818 0.64 DYRK1A (0.37) S1PR3METNQO2DYRK1AKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265614-A1 IMIDAZO [1,2-B]PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE Novartis AG (CH) 2010-12-29 EP disclosed
WO-2009106577-A1 IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE NOVARTIS AG (CH) 2009-09-03 WO disclosed